Detection of Serrated Polyps Improved With Propofol During Colonoscopy
By Elana Gotkine HealthDay Reporter
THURSDAY, April 18, 2024 -- Propofol sedation during colonoscopy seems to be associated with improved detection of serrated polyps, according to a study published online April 17 in Anesthesiology.
Aurora N. Quaye, M.D., from Maine Medical Center in Portland, and colleagues conducted a retrospective cohort study using observational data for patients aged older than 50 years with screening or surveillance colonoscopies between Jan. 1, 2015, and Feb. 28, 2020. The differences in polyp detection between propofol and moderate sedation were examined in the full sample (54,063 colonoscopies). In a restricted sample that included endoscopists and facilities with between 5 and 95 percent propofol sedation use (18,998 coloscopies), propensity score adjustment and clustering at the endoscopist level were used.
The researchers found that the prevalence of serrated polyps was significantly higher using propofol than moderate sedation in the full sample (34.0 versus 24.5 percent) and in the restricted sample (30.3 versus 25.7 percent). Propofol was associated with higher neoplasm, adenoma, and serrated polyp detection in the full-sample multivariate logistic regression (adjusted odds ratios, 1.25, 1.07, and 1.51, respectively). An attenuated but statistically significant effect size was seen for serrated polyps (odds ratio, 1.13), but not for adenomas or any neoplastic lesion in the restricted sample using inverse probability of treatment-weighted propensity score adjustment and clustering at the endoscopist level.
"It may be that propofol increases patient comfort and relaxation, optimizing detection of polyps that are more difficult to see," Quaye said in a statement. "Additionally, propofol may cause smooth muscle relaxation in the colon, allowing more careful inspection and improved visualization."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted April 2024
Read this next
Neoadjuvant Nivolumab, Ipilimumab Safe for dMMR Colon Cancer
WEDNESDAY, June 5, 2024 -- Neoadjuvant nivolumab plus ipilimumab has an acceptable safety profile in patients with locally advanced mismatch repair-deficient (dMMR) colon cancer...
Lowering FIT Positivity Thresholds Improves Sensitivity, Specificity
WEDNESDAY, June 5, 2024 -- Lowering the fecal immunochemical test (FIT) positive threshold yields levels of sensitivity and specificity that are comparable to those reported for...
Digestive Disease Week, May 18-21
Digestive Disease Week, the annual meeting sponsored by the American Association for the Study of Liver Diseases, American Gastroenterological Association, American Society for...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.